Comparison of two rapid tests for anti-phenolic glycolipid-i serology in Brazil and Nepal

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue SUPPL.1, 2012, Pages 124-131

  Stefani, Mariane Martins de Araújo ^a   Grassi, Adriano Badotti ^a   Sampaio, Lucas Henrique ^a   de Sousa, Ana Lúcia Osório Maroclo ^a   Costa, Maurício Barcelos ^a   Scheelbeek, Pauline ^b   Neupane, Kapil D ^c   Hagge, Deanna A ^c   Macdonald, Murdo ^c   Cho, Sang Nae ^d   Oskam, Linda ^b   Bührer Sékula, Samira ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b ROYAL TROPICAL INSTITUTE   (Netherlands)

^c Anandaban Leprosy Hospital   (Nepal)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Immunochromatography; Leprosy; Serologic tests

Indexed keywords

BACTERIAL ANTIGEN; GLYCOLIPID; IMMUNOGLOBULIN CLASS; PHENOLIC GLYCOLIPID I, MYCOBACTERIUM LEPRAE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BRAZIL; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; DIAGNOSTIC KIT; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; IMMUNOLOGY; LEPROSY; MALE; METHODOLOGY; MIDDLE AGED; MYCOBACTERIUM LEPRAE; NEPAL; PREDICTIVE VALUE; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BRAZIL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOLIPIDS; HUMANS; IMMUNOASSAY; IMMUNOCHROMATOGRAPHY; IMMUNOGLOBULIN ISOTYPES; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; NEPAL; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84871518710     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762012000900019     Document Type: Article

References (20)

1. Brett SJ, Payne SN, Gigg J, Burgess P, Gigg R 1986. Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid-I in the serology of leprosy. Clin Exp Immunol 64: 476-483.
2. Bührer-Sékula S, Illarramendi X, Teles RB, Penna ML, Nery JA, Sales AM, Oskam L, Sampaio EP, Sarno EN 2009. The additional benefit of the ML Flow test to classify leprosy patients. Acta Trop 111: 172-176.
3. Bührer-Sékula S, Smits HL, Gussenhoven GC, van Ingen CW, Klatser PR 1998. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Am J Trop Med Hyg 58: 133-136.
4. Bührer-Sékula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, Fujiwara T, Klatser PR, Oskam L 2003. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 41: 1991-1995.
5. Chanteau S, Cartel JL, Celerier P, Plichart R, Desforges S, Roux J 1989. PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy. Int J Lepr Other Mycobact Dis 57: 735-743.
6. Cho SN, Cellona RV, Fajardo Jr TT, Abalos RM, la Cruz EC, Walsh GP, Kim JD, Brennan PJ 1991. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens. Int J Lepr Other Mycobact Dis 59: 25-31.
7. Cho SN, Fujiwara T, Hunter SW, Rea TH, Gelber RH, Brennan PJ 1984. Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl epitope for the serodiagnosis of leprosy. J Infect Dis 150: 311-322.
8. Chujor CS, Bernheimer H, Levis WR, Schwerer B 1991. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts. Int J Lepr Other Mycobact Dis 59: 441-449.
9. Dockrell HM, Geluk A, Brennan P, Saunderson PR, Oskam L, Lockwood DN, Xiaoman W, Richardus JH 2011. Report on the sixth meeting of the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) consortium held in Beijing, China on 23-25 August 2010. Lepr Rev 82: 80-85.
10. Douglas JT, Worth RM 1984. Field evaluation of an ELISA to detect antibody in leprosy patients and their contacts. Int J Lepr Other Mycobact Dis 52: 26-33.
11. Moura RS, Calado KL, Oliveira ML, Bührer-Sékula S 2008. Leprosy serology using PGL-I: a systematic review. Rev Soc Bras Med Trop 41 (Suppl.): 11-18.
12. Oskam L, Slim E, Bührer-Sékula S 2003. Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev 74: 196-205.
13. Petchclai B, Khupulsup K, Hiranras S, Sampatavanich S, Sampoonachot P, Leelarusamee A 1988. A passive hemagglutination test for leprosy using a synthetic disaccharide antigen. Int J Lepr Other Mycobact Dis 56: 255-258.
14. Ridley DS, Jopling WH 1966. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34: 255-273.
15. Saad MH, Medeiros MA, Gallo ME, Gontijo-Filho PP, Fonseca LS 1991. The dot-ELISA test for the detection of anti-PGL-1 IgM in leprosy patients and their contacts. Braz J Med Biol Res 24: 441-448.
16. Sampaio LH, Stefani MM, Oliveira RM, Sousa AL, Ireton GC, Reed SG, Duthie MS 2011. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC Infect Dis 11: 26.
17. Scollard DM 2008. The biology of nerve injury in leprosy. Lepr Rev 79: 242-253.
18. WHO - World Health Organization 1988. WHO Expert Committee on Leprosy, Sixth Report. WHO Tech Rep Ser 874: 1-143.
19. WHO - World Health Organization 1998. WHO Expert Committee on Leprosy, WHO, Geneva, 73 pp.
20. WHO - World Health Organization 2010. Global leprosy situation 2010. Wkly Epidemiol Rec 85: 337-348.